Payer Access & Market Share
Payer Access & Market Share: Gaining & Maintaining Return on Investment
We measure success by gaining payer access and market share; and maintaining long-term relationships to minimize change. A consistent strategy not only minimizes patient disruption, but also facilitates the best rebate strategy. Manufacturers get return on their rebate investment. Payers minimize their administrative costs , while maximizing pharmaceutical reimbursement. Our team has a proven record for negotiating long-term, consistent strategies for pharmaceutical and biotech companies in all managed markets. Critical to long-term success is the ability to change the course. When change is needed, it must be implemented with a comprehensive strategy to minimize disruption and cost. Gaining and maintaining return on investments requires the following:
- Fostering ongoing relationships and payer access with key decision makers
- Refreshed product landscape, including emerging Specialty and biosimilar market analysis
- Market research and reimbursement strategy refinement based on managed market drivers
- Negotiation, renewal and revision of pricing and rebate strategies
- Development of case studies, HEOR outcomes and training
- Revised Commercial, Medicaid and Medicare strategy and positioning as product landscape and data changes
- Review and revision of pull through programs, training and materials to maintain payer access and partnership
- Monitoring and refinement of key deliverable in the 10 year product lifecycle plan including product team responsibilities
- Prioritization of payer segments and rebate strategy investments